The Lung Cancer Screening Market is expanding as healthcare providers increase efforts to detect lung cancer at earlier stages and improve patient outcomes. The market is projected to reach US$ 4,363.95 million by 2030 from US$ 2,326.5 million in 2022, registering a compound annual growth rate (CAGR) of 8.2% from 2022 to 2030. Rising awareness of early cancer detection, advancements in medical...